Cargando…

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma

BACKGROUND: Glioblastoma is the most common malignancy of the neuroepithelium, yet existing research on this tumor is limited. LASSO is an algorithm of selected feature coefficients by which genes associated with glioblastoma prognosis can be obtained. METHODS: Glioblastoma-related data were selecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yin, Chen, Li’e, Jiang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888488/ https://www.ncbi.nlm.nih.gov/pubmed/36733371 http://dx.doi.org/10.3389/fonc.2022.1057383

Ejemplares similares

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
por: Luo, YingHao, et al.
Publicado: (2023)

RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022)

Screening Potential Diagnostic Biomarkers for Age-Related Sarcopenia in the Elderly Population by WGCNA and LASSO
por: Lin, Shangjin, et al.
Publicado: (2022)

Development of a Novel Prognostic Model of Glioblastoma Based on m6A-Associated Immune Genes and Identification of a New Biomarker
por: Luo, Na, et al.
Publicado: (2022)

SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma
por: Lié, Oriane, et al.
Publicado: (2022)

Multiparametric MRI and [(18)F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma
por: Hassanzadeh, Comron, et al.
Publicado: (2017)

Parkinson’s Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms
por: Bao, Yiwen, et al.
Publicado: (2023)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Screening the Influence of Biomarkers for Metabolic Syndrome in Occupational Population Based on the Lasso Algorithm
por: Xie, Qiao-Ying, et al.
Publicado: (2021)

Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso
por: Du, Zixuan, et al.
Publicado: (2021)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
por: Zheng, Guo-Liang, et al.
Publicado: (2022)

A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction
por: Niu, Xuegang, et al.
Publicado: (2020)

Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme
por: Tang, Guihua, et al.
Publicado: (2020)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis
por: Yang, Ji’an, et al.
Publicado: (2021)

Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
por: Luo, Bin, et al.
Publicado: (2022)

A LASSO-based model to predict central lymph node metastasis in preoperative patients with cN0 papillary thyroid cancer
por: Zhao, Feng, et al.
Publicado: (2023)

Construction and Characterization of Long Non-Coding RNA-Associated Networks to Reveal Potential Prognostic Biomarkers in Human Lung Adenocarcinoma
por: Zhou, Wenting, et al.
Publicado: (2021)

Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
por: Li, Junhong, et al.
Publicado: (2022)

Biomarker-based prognostic stratification of young adult glioblastoma
por: Zhang, Rui-qi, et al.
Publicado: (2015)

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy
por: Ming, Cheng, et al.
Publicado: (2023)

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
por: Tan, Qiaorui, et al.
Publicado: (2022)

HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis
por: Wei, Fang-Ze, et al.
Publicado: (2022)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis
por: Hao, Chengcheng, et al.
Publicado: (2020)

Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases
por: Wang, Lulu, et al.
Publicado: (2022)

Dictionary learning LASSO for feature selection with application to hepatocellular carcinoma grading using contrast enhanced magnetic resonance imaging
por: Lei, Lei, et al.
Publicado: (2023)

HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer
por: Huang, Zhijian, et al.
Publicado: (2022)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

FCGR3A: A new biomarker with potential prognostic value for prostate cancer
por: Zha, Zeyu, et al.
Publicado: (2022)

LassoProt: server to analyze biopolymers with lassos
por: Dabrowski-Tumanski, Pawel, et al.
Publicado: (2016)

HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer
por: Ji, Ce, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_de2vmg9c08cbo2h8retoqmpqku